Division of Diabetes Endocrinology and Metabolism

June 8, 2017

NIDDK renews Vanderbilt’s diabetes research grant

The Vanderbilt Diabetes Research and Training Center (VDRTC) is celebrating its 44th year of operation with a five-year competitive renewal of its $9 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH).

By Jill Clendening
May 4, 2017

Three faculty members elected to Association of American Physicians

The Association of American Physicians (AAP) is an honorary medical society founded in 1885 by Sir William Osler and six other physicians for “the advancement of scientific and practical medicine.” This year, 60 additional physician scientists were elected to the association, including three Vanderbilt faculty members.

By Paul Govern
Insulin in vials
May 3, 2017

Therapeutic targets for diabetes

Vanderbilt investigators have identified novel regulators of insulin-producing beta-cell proliferation and survival, suggesting new targets for the treatment of type 2 diabetes.

By Leigh MacMillan
February 7, 2017

Dementia linked to diet

Some memory deficits observed in Alzheimer’s disease may be due to co-morbid illnesses – not the disease itself – and may be reversed by lifestyle changes or pharmacologic interventions.

By VUMC News and Communications
Insulin in vials
December 8, 2016

Making human beta cells reproduce

A new method developed at Vanderbilt will speed the search for potential therapeutics for diabetes: compounds that stimulate the replication of insulin-producing beta cells.

By VUMC News and Communications
November 17, 2016

V Foundation grants bolster cancer initiatives

Two Vanderbilt-Ingram Cancer Center (VICC) investigators have earned grant awards from The V Foundation for Cancer Research, continuing the foundation’s support for innovative cancer research initiatives at VICC.

By VUMC News and Communications
June 23, 2016

It takes two to tango: beta cell development

Defining the genes required for the function of insulin-producing beta cells is crucial for ongoing efforts to develop a cell-based therapy for diabetes.
By Bill Snyder
May 26, 2016

Family’s diabetes experiences propel Tour de Cure participation

When the Mullis family straps on their helmets on June 11 to ride in the local Tour de Cure, one of a series of cycling events held nationally to benefit the American Diabetes Association (ADA), they will remember a day seven years ago that motivated their annual participation in the event.
By Jill Clendening
May 13, 2016

Vanderbilt University honors 24 as emeriti faculty

Twenty-four retiring faculty members were recognized during Vanderbilt’s Commencement ceremony May 13, when the university honored their years of service and bestowed on them the title of emeritus or emerita faculty.
By VUMC News and Communications
May 5, 2016

Gannon to chair ADA science session planning committee

Maureen Gannon, Ph.D., associate professor of Medicine, has been appointed chair of the American Diabetes Association (ADA) Scientific Session planning committee.
By Bill Snyder
January 21, 2016

Vanderbilt’s Powers named president-elect of ADA

Alvin Powers, M.D., director of the Vanderbilt Diabetes Center, has been named president-elect, Medicine and Science, of the American Diabetes Association (ADA) for 2016.
By Bill Snyder
January 14, 2016

Major grants bolster VUMC diabetes research

Researchers at Vanderbilt University Medical Center have received more than $11 million in new grant support aimed at slowing the growing burden of diabetes.
By Bill Snyder
August 20, 2015

New therapeutic target for diabetes

The factor FoxM1 increases the proliferation and function of insulin-producing beta cells, making it an attractive therapeutic target for diabetes.
By Leigh MacMillan
1 … 3 4 5 6 7